Micell Technologies Revenue and Competitors

Location

$90.1M

Total Funding

Estimated Revenue & Valuation

  • Micell Technologies's estimated annual revenue is currently $1.5M per year.(i)
  • Micell Technologies's estimated revenue per employee is $125,500
  • Micell Technologies's total funding is $90.1M.

Employee Data

  • Micell Technologies has 12 Employees.(i)
  • Micell Technologies grew their employee count by 0% last year.

Micell Technologies's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$15.1M607%N/AN/A
#3
$6M240%N/AN/A
#4
$24.8M99-12%N/AN/A
#5
$19.3M778%N/AN/A
#6
$28.1M11220%N/AN/A
#7
$3.8M15-46%N/AN/A
#8
$19.3M774%N/AN/A
#9
$45.4M1814%N/AN/A
#10
$6.8M27N/AN/AN/A
Add Company

What Is Micell Technologies?

Welcome to Micell Technologies, Inc., a privately-held, early-stage biomedical company dedicated to advancing combination product therapies in the cardiovascular, orthopedic, and drug-delivery areas. Our Supercritical Fluid Technology consists of patented processes and methods for surface modifications of medical devices with specific focus on improvements to current polymer based drug-eluting technologies. Included in our technology platform are exclusively licensed patents from Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.

keywords:N/A

$90.1M

Total Funding

12

Number of Employees

$1.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Micell Technologies News

2009-09-21 - USA, Micell Receives $15 Million Equity Investment

Raleigh, NC.-based Micell Technologies, a development-stage biomedical company dedicated to developing innovative interventional cardiology systems, announced today that St. Jude Medical, Inc. has made a $15m equity investment in the company. Commenting on the deal, Arthur J. Benvenuto, chairma ...

2007-07-12 - Micell: A materials chameleon tackles drug-coated devices

For Micell Technologies, a Raleigh, N.C., materials company that recently reinvented itself as a developer of drug-releasing stents, perhaps the third time will be the charm. Founded in 1995, Micell specializes in the use of supercritical fluids, which are highly compressed gases that exhibit b ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M120%N/A
#2
$1M120%N/A
#3
$1.6M120%N/A
#4
$1M12N/AN/A
#5
$2.4M120%N/A